CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 50 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $64,118,000 | -40.8% | 2,040,021 | -11.3% | 2.98% | -31.1% |
| Q4 2019 | $108,353,000 | +1282.4% | 2,300,000 | +89.6% | 4.32% | +806.5% |
| Q3 2019 | $7,838,000 | -49.8% | 1,213,274 | -4.6% | 0.48% | -46.8% |
| Q2 2019 | $15,616,000 | -9.4% | 1,271,685 | -0.0% | 0.90% | -23.0% |
| Q1 2019 | $17,231,000 | +237.9% | 1,271,687 | 0.0% | 1.16% | +181.4% |
| Q4 2018 | $5,099,000 | -40.4% | 1,271,687 | 0.0% | 0.41% | -25.5% |
| Q3 2018 | $8,558,000 | – | 1,271,687 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |